# Prognostic Biomarkers in Patients With Endometrial Cancer

> **NCT01208467** · — · COMPLETED · sponsor: **Gynecologic Oncology Group** · enrollment: 2824 (estimated)

## Conditions studied

- Endometrial Adenocarcinoma
- Recurrent Uterine Corpus Carcinoma
- Stage I Uterine Corpus Cancer
- Stage II Uterine Corpus Cancer
- Stage III Uterine Corpus Cancer
- Stage IV Uterine Corpus Cancer

## Interventions

- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT01208467
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2014-05
- **Final completion:** —
- **Target enrollment:** 2824 (ESTIMATED)
- **Last updated:** 2017-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01208467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01208467, "Prognostic Biomarkers in Patients With Endometrial Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01208467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*